Full-Time

Growth Marketing Lead

Mednet

Mednet

11-50 employees

Specialized oncology knowledge platform for clinicians

Compensation Overview

$115k - $165k/yr

New York, NY, USA

In Person

Category
Growth & Marketing (1)
Required Skills
Mixpanel
Amplitude
Google AdWords
Data Analysis
Google Analytics

Get referred to Mednet

See people who can refer or advise you

Requirements
  • At least 5 years of growth, acquisition, or performance marketing experience, ideally at an early-stage startup where the candidate handled multiple responsibilities.
  • A track record of finding and scaling acquisition channels from scratch rather than only optimizing a single assigned channel.
  • An experiment-first approach involving hypotheses, frequent testing, and the ability to distinguish meaningful results from noise.
  • Strong creative and writing instincts, including the ability to write sharp copy and direct creative with production support.
  • Experience running email as a growth channel, including list segmentation, personalization at scale, deliverability, and maintaining engagement with a large list.
  • Comfort with analytics and attribution, including building and interpreting funnel reports and acting without waiting for a data team.
  • The ability to work autonomously on a small, fast-moving team, set priorities, and own outcomes.
  • Experience marketing to credentialed or high-trust professional audiences, such as physicians, attorneys, or financial advisors, where adoption depends on relevance and credibility.
Responsibilities
  • Own top-of-funnel growth, including how physicians discover Mednet, why they register, and registration volume.
  • Find and test acquisition channels including paid, organic, referral, partnerships, outbound, and content, then invest in effective channels and discontinue ineffective ones.
  • Run a high-velocity experimentation program across messaging, audiences, creative, and channels, with a clear interpretation of each test's findings.
  • Build acquisition campaigns for physicians using specialty-level targeting and positioning aligned with physicians' perspectives on their practices.
  • Run the email acquisition engine by improving segmentation and personalization at scale across physician contacts, invitations, and the free newsletter.
  • Own acquisition messaging and creative direction to capture the attention of skeptical, time-constrained professionals, with support from creative producers.
  • Partner with lifecycle and product teams to transition newly acquired physicians into onboarding after registration.
  • Work with data to instrument the funnel, define required events and sources, and report on cost, conversion, and the quality of acquired physicians.
Desired Qualifications
  • Experience marketing to physicians or other healthcare professionals specifically.
  • Background with community, marketplace, or user-generated content products, where growth depends on more than a one-time signup.
  • Hands-on experience with paid channels such as Meta, Google, and LinkedIn, including the conversion tracking behind them.
  • Comfort with analytics tools such as Google Analytics, Mixpanel, or Amplitude.

theMednet provides a specialized online platform that shares expert oncology knowledge sourced from National Cancer Institute Cancer Center Tumor Boards. It targets healthcare professionals and researchers, offering access to curated opinions and treatment insights to support clinical decision-making. Access is via a subscription model and partnerships with medical institutions, enabling members to view tumor board discussions, expert commentary, and research ideas that inform patient care. The platform differentiates itself by focusing on tumor-board-level expertise and formal collaborations with cancer centers, rather than general medical information. Its goal is to improve patient outcomes and accelerate cancer research by giving clinicians and researchers reliable, board-vetted guidance when planning treatment and evaluating new research directions.

Company Size

11-50

Company Stage

Grant

Total Funding

$1.7M

Headquarters

New York City, New York

Founded

2014

Get referred to Mednet

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 20, 2026 TrialMatch launch gives Mednet a fresh NCI-backed growth narrative.
  • SWOG’s 2026 evaluation can validate AI matching and unlock institutional adoption.
  • Oncologists already using Mednet can adopt TrialMatch without workflow disruption, reducing sales friction.

What critics are saying

  • TrialMatch’s $2 million NCI contract expires soon if SWOG validation misses enrollment gains.
  • Free access to oncologists weakens pricing power and delays durable subscription revenue growth.
  • TheMednet’s value depends on physician participation; any engagement drop destroys network effects.

What makes Mednet unique

  • August 2026 TrialMatch embeds trial discovery inside oncologists’ daily Mednet workflow.
  • Mednet claims 40,000+ active physicians and 3,400+ academic experts across 23 specialties.
  • Its 22,000+ expert-answered oncology discussions create proprietary clinician intent data competitors lack.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

2%

1 year growth

6%

2 year growth

4%
Scientist Live
Aug 21st, 2026
Mednet launches new clinical trial discovery tool.

Mednet launches new clinical trial discovery tool. Published: 21 August 2026 Mednet has launched TrialMatch, a clinical trial discovery tool designed to help oncologists identify relevant cancer trials in minutes. Developed through a $2 million contract awarded by the National Cancer Institute (NCI) Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR), TrialMatch brings clinical trial discovery into the physician workflow Clinical trial enrollment is still a challenge in oncology. 20% of trials close prematurely due to insufficient enrollment, while 93% of adults with cancer never participate in a clinical trial. Eligible patients exist, but identifying appropriate trials requires physicians to navigate complex eligibility criteria and trial registries designed for researchers instead of practising physicians. TrialMatch addresses both sides of this challenge: enabling oncologists to find relevant trials for their patients, and helping trials find the physicians already caring for potentially eligible patients. Using Mednet AI, Mednet's clinical assistant, oncologists can describe a patient profile in natural language and identify open trials matched on factors such as diagnosis, stage, biomarkers, and location. Results include match rationales and enrollment links, helping physicians evaluate potential opportunities without leaving their clinical workflow. TrialMatch also operates within Mednet's physician community, where oncologists ask questions, discuss challenging cases, and share clinical experience with peers. There, TrialMatch surfaces enrolling trials within the 22,000+ conversations where physicians are seeking guidance. Nadine Housri, MD, co-founder and chief medical officer of Mednet, said, "Finding the right clinical trial shouldn't require physicians to step away from patient care and search through multiple databases. But discovery is only one part of the challenge. Physicians need easier ways to identify appropriate trials for their patients, and trials need better ways to reach the clinicians caring for those patients. TrialMatch brings both sides together by making clinical trial discovery part of the everyday practice of medicine." Over 45,000 physicians across 23 specialities use Mednet to discuss complex clinical questions, share insights, and learn from each other's experience. In addition to supporting the development of TrialMatch, the NCI SBIR/STTR contract funds a prospective evaluation of the tool in collaboration with the SWOG Cancer Research Network, one of five adult cooperative groups in the NCI-sponsored National Clinical Trials Network (NCTN). The study will examine whether AI-assisted trial matching increases physician awareness of clinical trials and ultimately improves patient enrollment. SWOG has led many of oncology's most influential practice-changing clinical trials over the past several decades, and the collaboration brings SWOG's commitment to scientific rigour and evidence-based evaluation to the development and validation of TrialMatch. TrialMatch is available now at no cost to oncologists through Mednet AI and across Mednet's physician community.

HIStalk Practice
Jun 25th, 2025
Home " News " Currently Reading:

EqualizeRCM invests in MedNet, which specializes in RCM services for physician practices and durable medical equipment providers.